Capital raised by Sensei Biotherapeutics
1 Form D filing · first filed Feb 2026 · Rockville, MD
President and Principal Executive Officer
Signatory on Sensei Biotherapeutics's Form D filings · $348.9M raised across 1
Christopher Gerry is on file as President and Principal Executive Officer at Sensei Biotherapeutics in Rockville, MD. Sensei Biotherapeutics has 1 Form D filing on record, $348.9M raised in total. Christopher Gerry appears as a signatory on the company's filings.
Acquired through the acquisition of Faeth Therapeutics, PIKTOR is Sensei's lead clinical program. It is an investigational multi-node inhibitor that targets the PI3K/AKT/mTOR cellular pathway, a critical pathway involved in cancer cell growth and survival. The company is developing it for the treatment of endometrial and breast cancer.
